NASDAQ : GNLX
Genelux Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 2.1 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 94.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Genelux Corporation (GNLX) reported revenue of 8.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 8.00K | 8.00K | 8.00K | 170.00K | 11.07M | |
| Gross Profit | 8.00K | 8.00K | 8.00K | 170.00K | 11.07M | |
| Selling, General & Admin | 13.86M | 13.48M | 12.83M | 11.90M | 5.00M | 8.29M |
| Research & Development | 22.57M | 19.75M | 18.87M | 12.44M | 9.08M | 6.32M |
| Operating Expenses | 36.43M | 33.22M | 31.70M | 24.34M | 14.08M | 14.61M |
| Operating Income | -36.42M | -33.21M | -31.70M | -24.16M | -3.01M | -14.61M |
| Interest Expense | -822.00K | -1.41M | -1.42M | |||
| Interest & Investment Income | 603.00K | 711.00K | 700.00K | 182.00K | ||
| Other Non Operating Income (Expenses) | 223.00K | 358.00K | 1.13M | -3.09M | -398.00K | |
| EBT Excluding Unusual Items | -35.60M | -32.15M | -29.87M | -27.89M | -4.42M | -16.43M |
| Other Unusual Items | -402.00K | 314.00K | 50.00K | |||
| Pretax Income | -35.60M | -32.15M | -29.87M | -28.30M | -4.11M | -16.38M |
| Income Tax Expense | 1.10M | |||||
| Net Income | -35.60M | -32.15M | -29.87M | -28.30M | -5.21M | -16.38M |
| Net Income to Common | -35.60M | -32.15M | -29.87M | -28.30M | -5.21M | -16.38M |
| Shares Outstanding (Basic) | 41.28M | 37.18M | 31.45M | 24.43M | 9.12M | 9.03M |
| Shares Outstanding (Diluted) | 41.28M | 37.18M | 31.45M | 24.43M | 9.12M | 9.03M |
| EPS (Basic) | -0.86 | -0.86 | -0.95 | -1.16 | -0.57 | -1.81 |
| EPS (Diluted) | -0.86 | -0.86 | -0.95 | -1.16 | -0.57 | -1.81 |
| Free Cash Flow | -28.68M | -26.37M | -21.61M | -21.30M | -3.62M | -6.58M |
| Free Cash Flow Per Share | -0.69 | -0.71 | -0.69 | -0.87 | -0.40 | -0.73 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -455,275.00% | -415,175.00% | -396,200.00% | -14,214.71% | -27.22% | |
| Profit Margin | -444,950.00% | -401,812.50% | -373,362.50% | -16,645.29% | -47.05% | |
| Free Cash Flow Margin | -358,537.50% | -329,575.00% | -270,112.50% | -12,529.41% | -32.71% | |
| EBITDA | -36.28M | -32.97M | -31.46M | -23.67M | -2.46M | -14.06M |
| EBITDA Margin | -22.23% | |||||
| D&A For EBITDA | 142.00K | 244.00K | 235.00K | 499.00K | 553.00K | 553.00K |
| EBIT | -36.42M | -33.21M | -31.70M | -24.16M | -3.01M | -14.61M |
| EBIT Margin | -27.22% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.18M | 5.33M | 8.56M | 9.42M | 397.00K | 4.50M |
| Short-Term Investments | 9.49M | 9.26M | 22.33M | 13.77M | ||
| Cash & Short-Term Investments | 18.67M | 14.60M | 30.89M | 23.19M | 397.00K | 4.50M |
| Prepaid Expenses | 474.00K | 535.00K | 653.00K | 1.01M | 1.50M | 1.33M |
| Total Current Assets | 19.14M | 15.13M | 31.55M | 24.20M | 1.89M | 5.82M |
| Property, Plant & Equipment | 6.92M | 3.75M | 3.08M | 3.60M | 1.98M | 2.21M |
| Long-Term Deferred Charges | 1.57M | |||||
| Other Long-Term Assets | 146.00K | 144.00K | 92.00K | 92.00K | 92.00K | 92.00K |
| Total Assets | 26.20M | 19.03M | 34.72M | 27.89M | 5.53M | 8.13M |
| Accounts Payable | 302.00K | 455.00K | 191.00K | 3.78M | 6.78M | 4.02M |
| Accrued Expenses | 7.37M | 5.34M | 6.38M | 2.12M | 7.85M | 7.40M |
| Short-Term Debt | 992.00K | |||||
| Current Portion of Long-Term Debt | 15.41M | 6.16M | ||||
| Current Portion of Leases | 326.00K | 427.00K | 329.00K | 653.00K | 266.00K | 402.00K |
| Current Unearned Revenue | 170.00K | 4.50M | ||||
| Other Current Liabilities | 169.00K | |||||
| Total Current Liabilities | 8.00M | 6.22M | 6.90M | 6.55M | 31.63M | 22.48M |
| Long-Term Debt | 8.52M | 18.02M | ||||
| Long-Term Leases | 2.09M | 1.26M | 1.54M | 1.87M | 1.16M | 731.00K |
| Total Liabilities | 10.09M | 7.48M | 8.44M | 8.42M | 41.31M | 41.24M |
| Common Stock | 45.00K | 38.00K | 35.00K | 27.00K | 9.00K | 9.00K |
| Additional Paid-In Capital | 318.44M | 295.47M | 278.00M | 241.39M | 154.40M | 151.87M |
| Retained Earnings | -301.94M | -283.54M | -251.39M | -221.52M | -189.78M | -184.58M |
| Treasury Stock | -433.00K | -433.00K | -433.00K | -433.00K | -433.00K | -433.00K |
| Comprehensive Income & Other | -2.00K | 9.00K | 64.00K | 14.00K | 2.00K | 2.00K |
| Total Common Equity | 16.11M | 11.54M | 26.27M | 19.47M | -35.80M | -33.13M |
| Shareholders' Equity | 16.11M | 11.54M | 26.27M | 19.47M | -35.78M | -33.11M |
| Total Liabilities & Equity | 26.20M | 19.03M | 34.72M | 27.89M | 5.53M | 8.13M |
| Total Debt | 2.42M | 1.69M | 1.87M | 2.52M | 26.35M | 25.31M |
| Net Cash (Debt) | 16.25M | 12.91M | 29.03M | 20.67M | -25.96M | -20.82M |
| Net Cash Per Share | 0.39 | 0.35 | 0.92 | 0.85 | -2.85 | -2.30 |
| Filing Date Shares Outstanding | 44.81M | 44.37M | 34.17M | 26.43M | 24.12M | 8.68M |
| Total Common Shares Outstanding | 44.67M | 37.71M | 34.29M | 26.36M | 8.69M | 8.68M |
| Working Capital | 11.15M | 8.90M | 24.64M | 17.65M | -29.73M | -16.66M |
| Book Value Per Share | 0.36 | 0.31 | 0.77 | 0.74 | -4.12 | -3.82 |
| Tangible Book Value | 16.11M | 11.54M | 26.27M | 19.47M | -35.80M | -33.13M |
| Tangible Book Value Per Share | 0.36 | 0.31 | 0.77 | 0.74 | -4.12 | -3.82 |
| Machinery | 3.27M | 3.19M | 3.14M | 3.07M | 3.04M | 2.99M |
| Construction In Progress | 4.73M | 2.35M | 1.30M | 995.00K | ||
| Leasehold Improvements | 557.00K | 557.00K | 557.00K | 557.00K | 557.00K | 557.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -35.60M | -32.15M | -29.87M | -28.30M | -5.21M | -16.38M |
| Depreciation & Amortization | 482.00K | 574.00K | 903.00K | 1.02M | 968.00K | 895.00K |
| Other Amortization | 649.00K | 258.00K | 196.00K | |||
| Loss (Gain) From Sale of Investments | -186.00K | -226.00K | -757.00K | -62.00K | ||
| Stock-Based Compensation | 8.62M | 7.58M | 8.11M | 6.14M | 2.42M | 4.27M |
| Other Operating Activities | -370.00K | 3.55M | -314.00K | 348.00K | ||
| Change in Accounts Payable | 896.00K | -1.21M | 2.16M | -2.36M | 2.31M | 754.00K |
| Change in Unearned Revenue | -170.00K | -4.33M | 4.50M | |||
| Change in Other Net Operating Assets | 511.00K | 167.00K | -1.41M | -753.00K | 326.00K | -1.17M |
| Operating Cash Flow | -25.28M | -25.27M | -21.23M | -20.27M | -3.57M | -6.58M |
| Capital Expenditures | -3.41M | -1.10M | -381.00K | -1.02M | -49.00K | |
| Investment in Securities | 12.12M | 13.24M | -7.75M | -13.70M | ||
| Investing Cash Flow | 8.71M | 12.14M | -8.13M | -14.72M | -49.00K | |
| Short-Term Debt Issued | 900.00K | 1.10M | ||||
| Long-Term Debt Issued | 937.00K | |||||
| Total Debt Issued | 900.00K | 1.10M | 937.00K | |||
| Short-Term Debt Repaid | -685.00K | |||||
| Long-Term Debt Repaid | -130.00K | -1.50M | ||||
| Total Debt Repaid | -685.00K | -130.00K | -1.50M | |||
| Net Debt Issued (Repaid) | 215.00K | 970.00K | -558.00K | |||
| Issuance of Common Stock | 19.20M | 9.89M | 28.51M | 44.11M | 120.00K | 288.00K |
| Other Financing Activities | -303.00K | -1.57M | ||||
| Financing Cash Flow | 19.20M | 9.89M | 28.51M | 44.02M | -478.00K | -270.00K |
| Net Cash Flow | 2.64M | -3.23M | -853.00K | 9.02M | -4.10M | -6.86M |
| Free Cash Flow | -28.68M | -26.37M | -21.61M | -21.30M | -3.62M | -6.58M |
| Free Cash Flow Margin | -358,537.50% | -329,575.00% | -270,112.50% | -12,529.41% | -32.71% | |
| Free Cash Flow Per Share | -0.69 | -0.71 | -0.69 | -0.87 | -0.40 | -0.73 |
| Levered Free Cash Flow | -15.25M | -14.36M | -10.14M | -17.41M | -304.12K | -533.75K |
| Unlevered Free Cash Flow | -15.25M | -14.36M | -10.14M | -17.54M | 317.88K | 155.88K |
| Cash Interest Paid | 72.00K | 264.00K | 912.00K | |||
| Change in Working Capital | 1.41M | -1.05M | 751.00K | -3.28M | -1.69M | 4.08M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 89.62M | 164.02M | 80.49M | 374.31M | ||
| Enterprise Value | 73.37M | 144.73M | 48.47M | 346.34M | ||
| Last Close Price | 2.00 | 4.36 | 2.36 | 14.01 | ||
| PS Ratio | 11,203.00 | 20,502.05 | 10,060.93 | 2,201.85 | ||
| PB Ratio | 5.54 | 14.21 | 3.06 | 19.22 | ||
| P/TBV Ratio | 5.56 | 14.21 | 3.06 | 19.22 | ||
| EV/Sales Ratio | 9,171.75 | 18,090.67 | 6,058.68 | 2,037.30 | ||
| Debt / Equity Ratio | 0.15 | 0.15 | 0.07 | 0.13 | -0.74 | -0.76 |
| Net Debt / Equity Ratio | -1.01 | -1.12 | -1.10 | -1.06 | -0.72 | -0.63 |
| Net Debt / EBITDA Ratio | 0.45 | 0.39 | 0.92 | 0.87 | -10.55 | -1.48 |
| Net Debt / FCF Ratio | 0.57 | 0.49 | 1.34 | 0.97 | -7.17 | -3.16 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 1.62 | |
| Quick Ratio | 2.33 | 2.35 | 4.48 | 3.54 | 0.01 | 0.20 |
| Current Ratio | 2.39 | 2.43 | 4.57 | 3.69 | 0.06 | 0.26 |
| Return on Equity (ROE) | -177.93% | -170.00% | -130.58% | |||
| Return on Assets (ROA) | -77.89% | -77.25% | -63.28% | -90.37% | -27.58% | -82.53% |
| Return on Capital Employed (ROCE) | -200.00% | -259.40% | -114.00% | -113.20% | 11.50% | 101.80% |
| Earnings Yield | -43.11% | -19.60% | -37.11% | -7.56% | ||
| FCF Yield | -32.00% | -16.07% | -26.85% | -5.69% | ||
| Buyback Yield / Dilution | -16.39% | -18.21% | -28.74% | -167.97% | -0.92% | -8.05% |